13 employees
Nobias Therapeutics is a developer of rare pediatric disease drugs intended to cure rare illnesses in children.
2020
$3.8M
from 1 investors over 1 rounds
Nobias Therapeutics raised $3.8M on July 24, 2020
Investors: Domain Associates